Guttman-Yassky E, Kabashima K, Worm M, Luna PC, et al. Efficacy and safety of rocatinlimab for the treatment of moderate-to-severe atopic dermatitis in ROCKET-IGNITE and ROCKET-HORIZON: two global, double-blind, placebo-controlled, randomised phase 3 clinical trials. Lancet 2025 Nov 25:S0140-6736(25)01865-3. doi: 10.1016/S0140-6736(25)01865.
PMID: 41314226